SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ben Nildus who wrote (836)7/22/1997 11:15:00 AM
From: Ben Nildus   of 1172
 
Cortecs/Astra Helisal Relationship Progresses

New Agreement For "One Step" Announced

biz.yahoo.com

LONDON--(HealthWire)--July 21, 1997-- Cortecs International (``Cortecs'') (NASDAQ:DLVRY / LSE:COR / ASX:CRI)
the U.K. based pharmaceutical company, today announced that
they have signed a new agreement with Astra to create
visibility in 33 countries (excluding Japan and the U.S.) for Cortecs' Helisal(TM) ``One Step'' diagnostic kit for the
detection of the bacterium Helicobacter pylori (``H. pylori'').
The new agreement runs until December 31, 1999. The agreement,
which is an extension to the current agreement
on Helisal(TM) Rapid Blood will automatically renew annually thereafter unless terminated by either party.

Sam.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext